MorphoSys AG Rings The Nasdaq Stock Market Opening Bell in Celebration of its IPO

mo_041918_hires-1

MorphoSys AG (Nasdaq: MOR), a late-stage, biopharmaceutical company devoted to the development of innovative and differentiated therapies for patients suffering from serious diseases, visits the Nasdaq MarketSite in Times Square.

Format

JPEG

Source

Nasdaq, Inc.

Downloads